Parkinson’s Disease

It is a progressive and chronic disorder, caused by death or malfunctioning of neurons, genetic mutation leading to decreased level of dopamine secretion. Associated effects are anxiety; depression, stress, ageing and neurodegenerative disorders, disease diagnostics, drug designing and therapeutics are the research areas.

The combined direct and indirect cost of Parkinson’s, including treatment, social security payments and lost income from inability to work, is estimated to be nearly $25 billion per year in the United States alone.Medication costs for an individual person with PD average $2,500 a year, and therapeutic surgery can cost up to $100,000 dollars per patient.

Parkinson’s disease (PD) is a chronic, progressive neurodegenerative disease most widely recognized for the profound degeneration of mid-brain dopamine nigrostriatal neurons linked to serious motor symptoms. Oral dopaminergic pharmaceuticals are effective in controlling these symptoms at early disease stages.

  • Impact of genetic mutations
  • Interdependent disorders such as neurodegenerative disorders and ageing
  • Anxiety, depression and stress level in Parkinson’s
  • Approaches involved in diagnostics
  • Drug desigining and therapeutics

Related Conference of Parkinson’s Disease

September 28-30, 2016

6th Pharmacovigilance Congress

Toronto, Ontario, Canada
October 03-04, 2016

International Conference on Pain Research & Management

Vancouver, Canada
October 10-12, 2016

8th Annual Pharma Middle East Congress

Dubai, UAE
Oct 31- Nov 02, 2016

5th International Conference on Forensic Research & Technology

San Francisco, California, USA
Nov 07-09, 2016

4th International Conference on Clinical Pharmacy

Las Vegas, Nevada, USA
Nov 07-09, 2016

World Pharma Congress

Las Vegas, Nevada, USA
April 17-18, 2017

8th Global Pharmacovigilance & Drug Safety Summit

Bali, Indonesia
May 15-17, 2017

7th European Biosimilars Congress

Munich, Germany
May 22-23, 2017

World Congress on Biotherapeutics

Mexico city, Mexico
July 10-12, 2017

9th Annual European Pharma Congress

Madrid, Spain
July 24-26, 2017

10th Asia-Pacific Pharma Congress

Melbourne, Australia
July 31-Aug 02, 2017

7th Global Experts Meeting on Neuropharmacology

Rome, Italy
August 03-04, 2017

4th International Conference and Exhibition on Pain Medicine

San Francisco, USA
August 07-09, 2017

8th World Congress on Pharmacology

Paris, France
August 17-18, 2017

11th Annual Global Pharma Summit

San Francisco, USA
April 27-28, 2017

2nd International Pharmacy Conference

Las Vegas, USA
Sep 25-27, 2017

8th Annual Pharmaceutical Analysis Congress

Vienna, Austria
October 16-18, 2017

World Congress on Natural Products Chemistry and Research

Budapest, Hungary
October 19-21, 2017

9th Annual Congress on Drug Formulation & Drug Design

Seoul, South Korea
October 23-25, 2017

International Conference on Biotech Pharmaceuticals

Paris, France
September 11-13, 2017

4th International Conference on Clinical Trails

San Antonio, USA

Parkinson’s Disease Conference Speakers

Recommended Sessions

Related Journals

Are you interested in